Skip to main content
Erschienen in: Supportive Care in Cancer 11/2015

01.11.2015 | Original Article

Follow-up care practices and barriers to breast cancer survivorship: perspectives from Asian oncology practitioners

verfasst von: Terence Ng, Ming Ren Toh, Yin Ting Cheung, Alexandre Chan

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study is to evaluate the perspectives of Asian oncology practitioners on the physical and psychosocial issues experienced by breast cancer survivors (BCS), current survivorship care practices, and the barriers to follow-up care.

Methods

This was a cross-sectional survey study. Oncology practitioners were recruited from a major cancer center in Singapore and through two regional cancer meetings that took place in Singapore and Malaysia in 2013.

Results

A total of 126 oncology practitioners from various Southeast Asian countries, mostly nurses (58.7 %) and physicians (37.3 %), were recruited. The majority of the respondents agreed that fatigue (78.4 %) and anxiety (69.1 %) were the most common physical and psychosocial problems experienced by BCS. Monitoring for physical and treatment-related adverse effects (80.7 %) and reviewing patients’ noncancer medical history (65.3 %) were the most practiced aspects of follow-up care. Compared with the other practitioners, the physicians were more likely to communicate with other healthcare professionals (adjusted OR = 4.24, 95 % CI 1.54 to 11.72; p = 0.005). Most of the respondents also agreed that patient-specific barriers were the main impediments to follow-up care.

Conclusion

This study provides insights into the various aspects of breast cancer survivorship care from the perspectives of oncology practitioners and shows that survivorship care is relatively inadequate in Asia. There is a need for new survivorship care models to meet the needs of Asian BCS and to complement the unique healthcare systems of Asia.
Literatur
1.
Zurück zum Zitat American Cancer Society (2012) Cancer treatment and survivorship facts & figures 2012-2013. American Cancer Society, Atlanta American Cancer Society (2012) Cancer treatment and survivorship facts & figures 2012-2013. American Cancer Society, Atlanta
2.
Zurück zum Zitat Stan D, Loprinzi CL, Ruddy KJ (2013) Breast cancer survivorship issues. Hematol Oncol Clin N Am 27:805–827CrossRef Stan D, Loprinzi CL, Ruddy KJ (2013) Breast cancer survivorship issues. Hematol Oncol Clin N Am 27:805–827CrossRef
3.
Zurück zum Zitat DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64:252–271CrossRefPubMed DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64:252–271CrossRefPubMed
4.
Zurück zum Zitat Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181CrossRefPubMed Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181CrossRefPubMed
5.
Zurück zum Zitat Ganz PA (2006) Monitoring the physical health of cancer survivors: a survivorship-focused medical history. J Clin Oncol 24:5105–5111CrossRefPubMed Ganz PA (2006) Monitoring the physical health of cancer survivors: a survivorship-focused medical history. J Clin Oncol 24:5105–5111CrossRefPubMed
6.
Zurück zum Zitat Ekwueme DU, Yabroff KR G, GP Jr, Banegas MP, de Moor JS, Li C HX, Zheng Z, Soni A, Davidoff A, Rechis R, KS V (2014) Medical costs and productivity losses of cancer survivors—United States, 2008-2011. MMWR Morb Mortal Wkly Rep 63: 505–510 Ekwueme DU, Yabroff KR G, GP Jr, Banegas MP, de Moor JS, Li C HX, Zheng Z, Soni A, Davidoff A, Rechis R, KS V (2014) Medical costs and productivity losses of cancer survivors—United States, 2008-2011. MMWR Morb Mortal Wkly Rep 63: 505–510
7.
Zurück zum Zitat Thewes B, Butow P, Girgis A, Pendlebury S (2004) The psychosocial needs of breast cancer survivors: a qualitative study of the shared and unique needs of younger versus older survivors. Psychooncology 13:177–189CrossRefPubMed Thewes B, Butow P, Girgis A, Pendlebury S (2004) The psychosocial needs of breast cancer survivors: a qualitative study of the shared and unique needs of younger versus older survivors. Psychooncology 13:177–189CrossRefPubMed
8.
Zurück zum Zitat Stanton AL (2006) Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 24:5132–5137CrossRefPubMed Stanton AL (2006) Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 24:5132–5137CrossRefPubMed
9.
Zurück zum Zitat Institute of Medicine and National Research Council (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington Institute of Medicine and National Research Council (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington
10.
11.
Zurück zum Zitat Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA, Syrjala KL, McCabe MS, Baker KS, Miller K, Casillas J, Rosenstein DL, Campbell M, Palmer SC (2011) Survivorship care planning after the institute of medicine recommendations: how are we faring? J Cancer Surviv 5:358–370CrossRefPubMed Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA, Syrjala KL, McCabe MS, Baker KS, Miller K, Casillas J, Rosenstein DL, Campbell M, Palmer SC (2011) Survivorship care planning after the institute of medicine recommendations: how are we faring? J Cancer Surviv 5:358–370CrossRefPubMed
12.
Zurück zum Zitat Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA (2013) Patient barriers to follow-up care for breast and cervical cancer abnormalities. J Wom Health (Larchmt) 22:507–517CrossRef Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA (2013) Patient barriers to follow-up care for breast and cervical cancer abnormalities. J Wom Health (Larchmt) 22:507–517CrossRef
13.
Zurück zum Zitat Lewis RA, Neal RD, Hendry M, France B, Williams NH, Russell D, Hughes DA, Russell I, Stuart NS, Weller D, Wilkinson C (2009) Patients' and healthcare professionals' views of cancer follow-up: systematic review. Br J Gen Pract 59:e248–e259PubMedCentralCrossRefPubMed Lewis RA, Neal RD, Hendry M, France B, Williams NH, Russell D, Hughes DA, Russell I, Stuart NS, Weller D, Wilkinson C (2009) Patients' and healthcare professionals' views of cancer follow-up: systematic review. Br J Gen Pract 59:e248–e259PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Hewitt ME, Bamundo A, Day R, Harvey C (2007) Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol 25:2270–2273CrossRefPubMed Hewitt ME, Bamundo A, Day R, Harvey C (2007) Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol 25:2270–2273CrossRefPubMed
15.
16.
Zurück zum Zitat Fu OS, Crew KD, Jacobson JS, Greenlee H, Yu G, Campbell J, Ortiz Y, Hershman DL (2009) Ethnicity and persistent symptom burden in breast cancer survivors. J Cancer Surviv 3:241–250CrossRefPubMed Fu OS, Crew KD, Jacobson JS, Greenlee H, Yu G, Campbell J, Ortiz Y, Hershman DL (2009) Ethnicity and persistent symptom burden in breast cancer survivors. J Cancer Surviv 3:241–250CrossRefPubMed
17.
Zurück zum Zitat Barnett V (2002) Sample survey: principles & methods. Arnold, London Barnett V (2002) Sample survey: principles & methods. Arnold, London
18.
Zurück zum Zitat Kelley K, Clark B, Brown V, Sitzia J (2003) Good practice in the conduct and reporting of survey research. Int J Qual Health Care 15:261–266CrossRefPubMed Kelley K, Clark B, Brown V, Sitzia J (2003) Good practice in the conduct and reporting of survey research. Int J Qual Health Care 15:261–266CrossRefPubMed
19.
Zurück zum Zitat Pirl WF, Muriel A, Hwang V, Kornblith A, Greer J, Donelan K, Greenberg DB, Temel J, Schapira L (2007) Screening for psychosocial distress: a national survey of oncologists. J Support Oncol 5:499–504PubMed Pirl WF, Muriel A, Hwang V, Kornblith A, Greer J, Donelan K, Greenberg DB, Temel J, Schapira L (2007) Screening for psychosocial distress: a national survey of oncologists. J Support Oncol 5:499–504PubMed
20.
Zurück zum Zitat Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA (2013) Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol 31:2322–2336PubMedCentralCrossRefPubMed Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA (2013) Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol 31:2322–2336PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112:2577–2592CrossRefPubMed Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112:2577–2592CrossRefPubMed
22.
Zurück zum Zitat Smith SL, Wai ES, Alexander C, Singh-Carlson S (2011) Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol 18:e218–e226PubMedCentralCrossRefPubMed Smith SL, Wai ES, Alexander C, Singh-Carlson S (2011) Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol 18:e218–e226PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Blanch-Hartigan DFL, Alfano CM, Smith T, Nekhlyudov L, Ganz PA, Rowland JH (2014) Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol 32:1578–1585PubMedCentralCrossRefPubMed Blanch-Hartigan DFL, Alfano CM, Smith T, Nekhlyudov L, Ganz PA, Rowland JH (2014) Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol 32:1578–1585PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Berger AM, Gerber LH, Mayer DK (2012) Cancer-related fatigue: implications for breast cancer survivors. Cancer 118:2261–2269CrossRefPubMed Berger AM, Gerber LH, Mayer DK (2012) Cancer-related fatigue: implications for breast cancer survivors. Cancer 118:2261–2269CrossRefPubMed
25.
Zurück zum Zitat Nekhlyudov L, Aziz NM, Lerro C, Virgo KS (2014) Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract 10:e29–e36PubMedCentralCrossRefPubMed Nekhlyudov L, Aziz NM, Lerro C, Virgo KS (2014) Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract 10:e29–e36PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106:751–758CrossRefPubMed Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106:751–758CrossRefPubMed
27.
Zurück zum Zitat Kenyon M, Mayer DK, Owens AK (2014) Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs 43:382–398CrossRefPubMed Kenyon M, Mayer DK, Owens AK (2014) Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs 43:382–398CrossRefPubMed
28.
Zurück zum Zitat Garcia-Torres F, Alos FJ (2014) Anxiety in common situations of everyday life in breast cancer survivors. Psychooncology 23:953–955CrossRefPubMed Garcia-Torres F, Alos FJ (2014) Anxiety in common situations of everyday life in breast cancer survivors. Psychooncology 23:953–955CrossRefPubMed
29.
Zurück zum Zitat Cheung YT, Lee HH, Chan A (2013) Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients. Support Care Cancer 21:2185–2194CrossRefPubMed Cheung YT, Lee HH, Chan A (2013) Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients. Support Care Cancer 21:2185–2194CrossRefPubMed
30.
Zurück zum Zitat Hartl K, Schennach R, Muller M, Engel J, Reinecker H, Sommer H, Friese K (2010) Quality of life, anxiety, and oncological factors: a follow-up study of breast cancer patients. Psychosomatics 51:112–123CrossRefPubMed Hartl K, Schennach R, Muller M, Engel J, Reinecker H, Sommer H, Friese K (2010) Quality of life, anxiety, and oncological factors: a follow-up study of breast cancer patients. Psychosomatics 51:112–123CrossRefPubMed
31.
Zurück zum Zitat Tan ML, Idris DB, Teo LW, Loh SY, Seow GC, Chia YY, Tin AS (2014) Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia Pac J Oncol Nurs 1:22–32CrossRef Tan ML, Idris DB, Teo LW, Loh SY, Seow GC, Chia YY, Tin AS (2014) Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia Pac J Oncol Nurs 1:22–32CrossRef
32.
Zurück zum Zitat Tomiak E, Piccart M (1993) Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future. Ann Oncol 4:199–204PubMed Tomiak E, Piccart M (1993) Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future. Ann Oncol 4:199–204PubMed
33.
Zurück zum Zitat de Bock GH, Bonnema J, Zwaan RE, van de Velde CJ, Kievit J, Stiggelbout AM (2004) Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer 90:1144–1150PubMedCentralCrossRefPubMed de Bock GH, Bonnema J, Zwaan RE, van de Velde CJ, Kievit J, Stiggelbout AM (2004) Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer 90:1144–1150PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Ng R, Verkooijen HM, Ooi LL, Koh WP (2012) Unmet psychosocial needs among cancer patients undergoing ambulatory care in Singapore. Support Care Cancer 20:1049–1056CrossRefPubMed Ng R, Verkooijen HM, Ooi LL, Koh WP (2012) Unmet psychosocial needs among cancer patients undergoing ambulatory care in Singapore. Support Care Cancer 20:1049–1056CrossRefPubMed
35.
Zurück zum Zitat McCaughan E, McSorley O (2007) Consumers' and professionals' perceptions of a breast cancer review clinic. J Adv Nurs 60:419–426CrossRefPubMed McCaughan E, McSorley O (2007) Consumers' and professionals' perceptions of a breast cancer review clinic. J Adv Nurs 60:419–426CrossRefPubMed
36.
Zurück zum Zitat Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH (2000) How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol 18:3295–3301PubMed Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH (2000) How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol 18:3295–3301PubMed
37.
Zurück zum Zitat Earle CC (2006) Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol 24:5112–5116CrossRefPubMed Earle CC (2006) Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol 24:5112–5116CrossRefPubMed
38.
Zurück zum Zitat Fagerlind H, Kettis A, Glimelius B, Ring L (2013) Barriers against psychosocial communication: oncologists' perceptions. J Clin Oncol 31:3815–3822CrossRefPubMed Fagerlind H, Kettis A, Glimelius B, Ring L (2013) Barriers against psychosocial communication: oncologists' perceptions. J Clin Oncol 31:3815–3822CrossRefPubMed
39.
Zurück zum Zitat Paradiso A, Nitti P, Frezza P, Scorpiglione N (1995) A survey in Puglia: the attitudes and opinions of specialists, general physicians and patients on follow-up practice. GSBioCaM Ann Oncol 6(Suppl 2):53–56CrossRef Paradiso A, Nitti P, Frezza P, Scorpiglione N (1995) A survey in Puglia: the attitudes and opinions of specialists, general physicians and patients on follow-up practice. GSBioCaM Ann Oncol 6(Suppl 2):53–56CrossRef
40.
Zurück zum Zitat Ganz PA, Hahn EE (2008) Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol 26:759–767CrossRefPubMed Ganz PA, Hahn EE (2008) Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol 26:759–767CrossRefPubMed
41.
Zurück zum Zitat Ferrell BR, Winn R (2006) Medical and nursing education and training opportunities to improve survivorship care. J Clin Oncol 24:5142–5148CrossRefPubMed Ferrell BR, Winn R (2006) Medical and nursing education and training opportunities to improve survivorship care. J Clin Oncol 24:5142–5148CrossRefPubMed
Metadaten
Titel
Follow-up care practices and barriers to breast cancer survivorship: perspectives from Asian oncology practitioners
verfasst von
Terence Ng
Ming Ren Toh
Yin Ting Cheung
Alexandre Chan
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2700-2

Weitere Artikel der Ausgabe 11/2015

Supportive Care in Cancer 11/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.